The therapeutic effect of dendritic cells expressing indoleamine 2,3-dioxygenase (IDO) on an IgA nephropathy mouse model
ConclusionsIt has the potential to treat IgAN by upregulating the expression of IDO in DC cells by genetic engineering and reinfusion into vivo.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research
More News: Arthritis | Fibre | Genetics | Glomerulonephritis | Renal Failure | Rheumatology | Study | Toxicology | Urology & Nephrology